Portugal INFARMED

Piasky (Crovalimab) – Public funding evaluation report available; preliminary assessment request approved

Original title: Piasky (Crovalimab) | Relatório de avaliação de financiamento público disponível na Infomed | Deferimento do pedido de avaliação prévia

INFARMED has approved the preliminary assessment request for Piasky (Crovalimab) and published the public funding evaluation report.

Low obligation Product class Pharmaceuticals Market Access & Reimbursement Portugal PharmaceuticalsReimbursement

SubscreverSubscrever Notícias

Read the official source ↗

Published by Portugal INFARMED. HealthSignal links to the original document; the summary above is extracted from the source text.